|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4122 USD | -0.79% |
|
+4.09% | +0.49% |
Evolution of the Average Target: Intensity Therapeutics, Inc.
Evolution of the Target Price: Intensity Therapeutics, Inc.
Changes in Analyst Recommendations: Intensity Therapeutics, Inc.
d71d6d42060.SkYkehsc6VH7GqhaZD41_TZvHThG4yxbCt71hnlHBQU.OjJcH3dUgRiRS_IfLWZ7zXgaKVIHqkM6TZzYx0gAYEMkNUsRX3O_aYJXyw~f23f08996ce8c861e644f2e990536b28
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +607.59% | |||||
| +19.85% | |||||
| +6.91% | |||||
| +20.42% | |||||
| +10.16% | |||||
| -24.09% | |||||
| -9.49% | |||||
| -6.11% | |||||
| +14.18% | |||||
| Average | +71.05% | |||||
| Weighted average by Cap. | +7.75% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
0.4122USD
Average target price
2.917USD
Spread / Average Target
+607.59%
High Price Target
5.000USD
Spread / Highest target
+1,113.00%
Low Price Target
1.500USD
Spread / Lowest Target
+263.90%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| Brookline Capital Markets | |
| Benchmark Company |
SellBuy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
0.4122USD
Average target price
2.917USD
Spread / Average Target
+607.59%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- INTS Stock
- Consensus Intensity Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
